澳大利亚与新西兰儿童及早发性青光眼分类与基因谱研究
基于澳大利亚与新西兰晚期青光眼登记库(ANZRAG),回顾性纳入290例儿童青光眼和370例早发性青光眼患者,采用CGRN分类系统。原发性青光眼最常见,儿童队列以原发性先天性青光眼(57.6%)为主,早发队列以青少年开角型青光眼(73.2%)为主。先证者基因检测诊断率为24.7%,10.4%的先证者青光眼亚型被重新分类。
要点
- 儿童青光眼以原发性先天性青光眼最常见(57.6%),早发性青光眼以青少年开角型青光眼为主(73.2%)。
- 先证者基因检测总体诊断率为24.7%,以CYP1B1双等位变异(23.2%)、MYOC杂合变异(19.2%)和FOXC1杂合变异(16.8%)最常见。
- 非获得性眼部异常相关青光眼的先证者分子诊断率最高(56.5%)。
核心结论
- 儿童及早发性青光眼以原发性青光眼最常见,CGRN分类可用于亚型划分。
- 先证者基因检测诊断率为24.7%,支持临床诊断与遗传咨询,但多数个体仍缺乏明确分子诊断。
研究设计与样本
- 回顾性临床与分子研究,纳入ANZRAG登记库中诊断年龄<40岁的青光眼患者。
- 儿童青光眼定义为0至<18岁诊断,早发性青光眼定义为18至<40岁诊断。
- 共纳入290例儿童青光眼(533眼)和370例早发性青光眼(686眼)。
- 采用CGRN分类系统确定青光眼亚型,对血液或唾液DNA进行青光眼相关基因测序。
主要发现
- 儿童队列中57.6%(167/290,303眼)为原发性先天性青光眼,19.3%(56/290,109眼)为青少年开角型青光眼。
- 早发性青光眼队列中青少年开角型青光眼占73.2%(271/370,513眼)。
- 先证者基因检测诊断率为24.7%(125/506),10.4%(13/125)的先证者青光眼亚型被重新分类。
- 非获得性眼部异常相关青光眼先证者的分子诊断率最高(56.5%)。
- 有分子诊断的先证者中最常见变异为CYP1B1双等位变异(n=29,23.2%)、MYOC杂合变异(n=24,19.2%)和FOXC1杂合变异(n=21,16.8%)。
临床怎么用
- 对儿童及早发性青光眼患者可采用CGRN分类系统进行亚型划分。
- 基因检测可支持临床诊断和遗传咨询,尤其在非获得性眼部异常相关青光眼患者中诊断率较高。
局限性
- 多数个体仍缺乏明确分子诊断,需国际协作识别更多致病基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the relative frequencies of childhood and early onset glaucoma subtypes and their genetic findings in a large single cohort. DESIGN: Retrospective clinical and molecular study. PARTICIPANTS: All individuals with childhood glaucoma (diagnosed 0 to <18 years) and early onset glaucoma (diagnosed 18 to <40 years) referred to a national disease registry. METHODS: We retrospectively reviewed the referrals of all individuals with glaucoma diagnosed at <40 years of age recruited to the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG). Subtypes of glaucoma were determined using the Childhood Glaucoma Research Network (CGRN) classification system. DNA extracted from blood or saliva samples underwent sequencing of genes associated with glaucoma. MAIN OUTCOME MEASURES: The phenotype and genotype distribution of glaucoma diagnosed at <40 years of age. RESULTS: A total of 290 individuals (533 eyes) with childhood glaucoma and 370 individuals (686 eyes) with early onset glaucoma were referred to the ANZRAG. Primary glaucoma was the most prevalent condition in both cohorts. In the childhood cohort, 57.6% of individuals (167/290, 303 eyes) had primary congenital glaucoma (PCG), and 19.3% (56/290, 109 eyes) had juvenile open-angle glaucoma. Juvenile open-angle glaucoma constituted 73.2% of the early onset glaucoma cohort (271/370, 513 eyes). Genetic testing in probands resulted in a diagnostic yield of 24.7% (125/506) and a reclassification of glaucoma subtype in 10.4% of probands (13/125). The highest molecular diagnostic rate was achieved in probands with glaucoma associated with nonacquired ocular anomalies (56.5%). Biallelic variants in CYP1B1 (n = 29, 23.2%) and heterozygous variants in MYOC (n = 24, 19.2%) and FOXC1 (n = 21, 16.8%) were most commonly reported among probands with a molecular diagnosis. Biallelic CYP1B1 variants were reported in twice as many female individuals as male individuals with PCG (66.7% vs. 33.3%, P = 0.02). CONCLUSIONS: We report on the largest cohort of individuals with childhood and early onset glaucoma from Australasia using the CGRN classification. Primary glaucoma was most prevalent. Genetic diagnoses ascertained in 24.7% of probands supported clinical diagnoses and genetic counseling. International collaborative efforts are required to identify further genes because the majority of individuals still lack a clear molecular diagnosis.
引用
- Knight LSW, Ruddle JB, Taranath DA, et al. Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry. Ophthalmology. 2021. PMID: 33892047. doi:10.1016/j.ophtha.2021.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。